The ACR and the AAHKS have released new guidelines on the management of antirheumatic medications in patients with rheumatic disease undergoing elective total knee or hip arthroplasty.
A recent study examined the impact of a nation-wide, non-medical switch from originator to biosimilar on disease activity and retention rates among patients with rheumatoid arthritis, psoriatic arthritis,...
